FeesSafety
Pluang+

Arbe Robotics to report Q3 2026 earnings and host conference call on Nov 19

Company Fundamentals
29 Oct 2026, 15:00 WIB
PRNewsWire
View Source
Neutral
Arbe Robotics to report Q3 2026 earnings and host conference call on Nov 19

Arbe Robotics Ltd., a leader in radar technology, will release its third quarter 2026 financial results on November 19 before the US market opens. The company will host a conference call the same day at 8:30 a.m. ET, featuring its top executives. Investors can access the call via webcast or phone, with pre-registration available. This update is important as it provides insight into Arbe's financial health and progress in the advanced radar market.

Arbe Robotics Ltd.'s upcoming Q3 2026 financial results announcement provides context for readers. For those following the Technology sector on Pluang as of Oct 29, 2026 18:11 WIB, 23 of 150 priced US stocks rose while 125 fell. Notable movers include HubSpot Inc (HUBS) at USD 231.99 with a -6.69% change and a typical hold time of 79 days, Nebius Group NV (NBIS) at USD 170.62 with a -6.43% change and a 33% Sell / 67% Buy order split, and Crowdstrike Holdings Inc (CRWD) at USD 250.00 with a -6.25% change and a 74% Sell / 26% Buy order split.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App